Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Head of Partnership Development - Americas New York, United States Head of Partnership Development - Americas New York, United States 1 week ago Use AI to assess how you fit Get AI-powered advice on this job and more
Unilabs is one of Europes leading diagnostics groups—processing over 237 million diagnostic tests annually across 14 countries. Unilabs.AI (ULAI) is a standalone, seed-stage company venture-backed by Unilabs and A.P. Møller Holding, built to turn this massive
Head of Global Supply Chain Location: Basel, BS, CH About Idorsia Pharmaceuticals Ltd Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from
About TetraScience TetraScience is the Scientific Data and AI Company building Tetra OS, the operating system for scientific intelligence. We help the world’s leading life sciences firms turn fragmented scientific data into AI-native assets and scientific
Job Purpose The VP, Medical Affairs, Rare Diseases BU will provide strategic medical leadership and oversight to support the continued growth of the Rare Diseases (RRD) portfolio. S/he will champion patient centricity as key driver of business
